| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.622 | 0.016 | 0.622 | Antibacterial | 0.536 0.032 DBMET02073 0.321 0.12 DBMET02075 0.499 0.041 DB12529 | ||
| 0.597 | 0.002 | 0.597 | Transcription factor NF kappa B stimulant | |||
| 0.535 | 0.005 | 0.702 | Alpha-N-acetylglucosaminidase inhibitor | 0.632 0.004 DBMET02073 0.619 0.004 DBMET00531 0.365 0.011 DBMET02074 0.702 0.003 DBMET02075 0.583 0.004 DB12529 | DBMET02075 | |
| 0.373 | 0.007 | 0.419 | UDP-glucose 4-epimerase inhibitor | 0.419 0.005 DBMET02073 0.309 0.01 DBMET00531 0.283 0.011 DBMET02074 0.371 0.007 DBMET02075 0.342 0.008 DB12529 | DBMET02073 | |
| 0.368 | 0.004 | 0.915 | Alcohol oxidase inhibitor | 0.604 0.003 DBMET02073 0.915 0.002 DBMET00531 0.155 0.01 DBMET02074 0.492 0.004 DBMET02075 0.332 0.004 DB12529 | DBMET00531 | |
| 0.397 | 0.047 | 0.619 | Aldehyde oxidase inhibitor | 0.548 0.026 DBMET02073 0.535 0.028 DBMET00531 0.193 0.108 DBMET02074 0.619 0.016 DBMET02075 0.507 0.032 DB12529 | DBMET02075 | |
| 0.345 | 0.005 | 0.596 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.416 0.004 DBMET02073 0.248 0.01 DBMET00531 0.596 0.001 DBMET02074 0.25 0.01 DBMET02075 0.289 0.007 DB12529 | DBMET02074 | |
| 0.327 | 0.004 | 0.4 | Triose-phosphate isomerase inhibitor | 0.4 0.003 DBMET02073 0.274 0.005 DBMET00531 0.205 0.01 DBMET02074 0.306 0.005 DBMET02075 0.301 0.005 DB12529 | DBMET02073 | |
| 0.316 | 0.009 | 0.366 | Succinate dehydrogenase inhibitor | 0.366 0.005 DBMET02073 0.303 0.01 DBMET00531 0.245 0.024 DBMET02074 0.337 0.006 DBMET02075 0.31 0.009 DB12529 | DBMET02073 | |
| 0.311 | 0.04 | 0.365 | DNA synthesis inhibitor | 0.365 0.027 DBMET02073 0.26 0.06 DBMET00531 0.258 0.062 DBMET02074 0.278 0.052 DBMET02075 0.298 0.044 DB12529 | DBMET02073 | |
| 0.301 | 0.037 | 0.456 | Peroxidase inhibitor | 0.398 0.021 DBMET02073 0.456 0.014 DBMET00531 0.21 0.057 DBMET02074 0.433 0.016 DBMET02075 0.441 0.015 DB12529 | DBMET00531 | |
| 0.302 | 0.05 | 0.4 | Superoxide dismutase inhibitor | 0.4 0.027 DBMET02073 0.342 0.038 DBMET00531 0.25 0.074 DBMET02074 0.316 0.045 DBMET02075 0.391 0.028 DB12529 | DBMET02073 | |
| 0.377 | 0.125 | 0.481 | Caspase 9 stimulant | 0.466 0.075 DBMET02073 0.429 0.095 DBMET00531 0.354 0.142 DBMET02074 0.404 0.109 DBMET02075 0.481 0.068 DB12529 | DB12529 | |
| 0.285 | 0.041 | 0.404 | Tyrosine 3 hydroxylase inhibitor | 0.326 0.023 DBMET02073 0.372 0.012 DBMET00531 0.292 0.037 DBMET02074 0.326 0.023 DBMET02075 0.404 0.008 DB12529 | DB12529 | |
| 0.336 | 0.094 | 0.592 | GABA C receptor rho-3 antagonist | 0.411 0.057 DBMET02073 0.592 0.008 DBMET00531 0.441 0.045 DBMET02074 0.448 0.042 DBMET02075 0.587 0.009 DB12529 | DBMET00531 | |
| 0.244 | 0.014 | 0.497 | GABA C receptor agonist | 0.318 0.008 DBMET02073 0.497 0.004 DBMET00531 0.269 0.012 DBMET02074 0.279 0.011 DBMET02075 0.466 0.004 DB12529 | DBMET00531 | |
| 0.241 | 0.011 | 0.292 | Adenylate kinase inhibitor | 0.292 0.007 DBMET02073 0.257 0.009 DBMET00531 0.215 0.013 DBMET02074 0.251 0.01 DBMET02075 0.279 0.008 DB12529 | DBMET02073 | |
| 0.236 | 0.008 | 0.279 | Phosphofructokinase-1 inhibitor | 0.279 0.006 DBMET02073 0.205 0.011 DBMET00531 0.169 0.015 DBMET02074 0.231 0.009 DBMET02075 0.213 0.01 DB12529 | DBMET02073 | |
| 0.254 | 0.03 | 0.303 | Nitric-oxide synthase stimulant | 0.287 0.015 DBMET02073 0.279 0.018 DBMET00531 0.266 0.023 DBMET02074 0.252 0.031 DBMET02075 0.303 0.011 DB12529 | DB12529 | |
| 0.304 | 0.088 | 0.396 | Calcium channel activator | 0.356 0.046 DBMET02073 0.355 0.046 DBMET00531 0.332 0.063 DBMET02074 0.297 0.094 DBMET02075 0.396 0.026 DB12529 | DB12529 | |
| 0.337 | 0.127 | 0.464 | 5 Hydroxytryptamine release inhibitor | 0.405 0.075 DBMET02073 0.464 0.046 DBMET00531 0.286 0.181 DBMET02074 0.455 0.049 DBMET02075 0.453 0.05 DB12529 | DBMET00531 | |
| 0.299 | 0.089 | 0.434 | Vasodilator, coronary | 0.361 0.05 DBMET02073 0.249 0.136 DBMET00531 0.257 0.128 DBMET02074 0.255 0.129 DBMET02075 0.434 0.026 DB12529 | DB12529 | |
| 0.219 | 0.018 | 0.378 | Ferrochelatase inhibitor | 0.28 0.009 DBMET02073 0.378 0.004 DBMET00531 0.265 0.011 DBMET02074 0.33 0.005 DBMET02075 0.356 0.004 DB12529 | DBMET00531 | |
| 0.343 | 0.158 | 0.514 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.398 0.103 DBMET02073 0.514 0.028 DBMET00531 0.422 0.082 DBMET02074 0.429 0.077 DBMET02075 0.512 0.029 DB12529 | DBMET00531 | |
| 0.195 | 0.011 | 0.239 | Creatine kinase inhibitor | 0.239 0.006 DBMET02073 0.2 0.01 DBMET00531 0.152 0.023 DBMET02074 0.216 0.008 DBMET02075 0.217 0.008 DB12529 | DBMET02073 | |
| 0.24 | 0.058 | 0.285 | Peptidyltransferase inhibitor | 0.285 0.031 DBMET02073 0.256 0.047 DBMET02075 | DBMET02073 | |
| 0.192 | 0.013 | 0.56 | Porphobilinogen synthase inhibitor | 0.259 0.007 DBMET02073 0.263 0.007 DBMET00531 0.205 0.012 DBMET02074 0.56 0.003 DBMET02075 0.281 0.006 DB12529 | DBMET02075 | |
| 0.227 | 0.054 | 0.284 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.283 0.029 DBMET02073 0.243 0.046 DBMET00531 0.211 0.063 DBMET02074 0.238 0.048 DBMET02075 0.284 0.029 DB12529 | DB12529 | |
| 0.231 | 0.063 | 0.29 | RNA-directed DNA polymerase inhibitor | 0.276 0.037 DBMET02073 0.268 0.041 DBMET00531 0.225 0.069 DBMET02074 0.261 0.043 DBMET02075 0.29 0.034 DB12529 | DB12529 | |
| 0.209 | 0.041 | 0.266 | Amylase inhibitor | 0.266 0.024 DBMET02073 0.16 0.059 DBMET00531 0.117 0.083 DBMET02074 0.229 0.034 DBMET02075 0.189 0.048 DB12529 | DBMET02073 | |
| 0.2 | 0.033 | 0.222 | Arachidonic acid antagonist | 0.215 0.021 DBMET02073 0.212 0.023 DBMET00531 0.176 0.058 DBMET02074 0.222 0.016 DBMET02075 0.214 0.021 DB12529 | DBMET02075 | |
| 0.166 | 0.01 | 0.207 | Carbamoyl phosphate synthetase inhibitor | 0.204 0.007 DBMET02073 0.196 0.008 DBMET00531 0.112 0.017 DBMET02074 0.207 0.007 DBMET02075 0.184 0.008 DB12529 | DBMET02075 | |
| 0.168 | 0.014 | 0.193 | DOPA decarboxylase inhibitor | 0.193 0.008 DBMET02073 0.166 0.015 DBMET00531 0.159 0.017 DBMET02074 0.154 0.019 DBMET02075 0.185 0.009 DB12529 | DBMET02073 | |
| 0.168 | 0.014 | 0.187 | Ca2+-transporting ATPase inhibitor | 0.178 0.008 DBMET02073 0.187 0.005 DBMET00531 0.162 0.021 DBMET02074 0.185 0.005 DBMET02075 0.187 0.005 DB12529 | DB12529 | |
| 0.189 | 0.037 | 0.23 | Mannose-6-phosphate isomerase inhibitor | 0.23 0.018 DBMET02073 0.199 0.031 DBMET00531 0.177 0.044 DBMET02074 0.183 0.04 DBMET02075 0.221 0.021 DB12529 | DBMET02073 | |
| 0.165 | 0.014 | 0.229 | NADH dehydrogenase inhibitor | 0.204 0.01 DBMET02073 0.229 0.009 DBMET00531 0.135 0.022 DBMET02074 0.215 0.009 DBMET02075 0.222 0.009 DB12529 | DBMET00531 | |
| 0.161 | 0.011 | 0.201 | Glutamate decarboxylase inhibitor | 0.201 0.007 DBMET02073 0.165 0.011 DBMET00531 0.128 0.018 DBMET02074 0.172 0.01 DBMET02075 0.167 0.01 DB12529 | DBMET02073 | |
| 0.154 | 0.009 | 0.211 | Biliverdin reductase inhibitor | 0.197 0.006 DBMET02073 0.19 0.006 DBMET00531 0.142 0.01 DBMET02074 0.146 0.01 DBMET02075 0.211 0.005 DB12529 | DB12529 | |
| 0.26 | 0.118 | 0.34 | Cholesterol antagonist | 0.329 0.074 DBMET02073 0.303 0.089 DBMET00531 0.34 0.069 DBMET02075 0.328 0.075 DB12529 | DBMET02075 | |
| 0.207 | 0.071 | 0.287 | Anesthetic general | 0.287 0.036 DBMET02073 0.227 0.061 DBMET00531 0.143 0.121 DBMET02074 0.283 0.038 DBMET02075 0.25 0.05 DB12529 | DBMET02073 | |
| 0.162 | 0.033 | 0.187 | Aminopeptidase B inhibitor | 0.187 0.024 DBMET02073 0.171 0.03 DBMET00531 0.137 0.044 DBMET02074 0.169 0.03 DBMET02075 0.183 0.026 DB12529 | DBMET02073 | |
| 0.15 | 0.033 | 0.181 | Sphingosine 1-phosphate receptor 4 antagonist | 0.181 0.014 DBMET02073 0.125 0.064 DBMET00531 0.135 0.049 DBMET02074 0.129 0.058 DBMET02075 0.144 0.039 DB12529 | DBMET02073 | |
| 0.136 | 0.022 | 0.206 | Histidine decarboxylase inhibitor | 0.206 0.012 DBMET02073 0.16 0.018 DBMET00531 0.126 0.024 DBMET02074 0.13 0.023 DBMET02075 0.192 0.014 DB12529 | DBMET02073 | |
| 0.127 | 0.021 | 0.181 | Glutamate dehydrogenase inhibitor | 0.161 0.014 DBMET02073 0.176 0.012 DBMET00531 0.119 0.023 DBMET02074 0.136 0.018 DBMET02075 0.181 0.012 DB12529 | DB12529 | |
| 0.119 | 0.014 | 0.221 | Aldose reductase inhibitor | 0.221 0.006 DBMET02073 0.14 0.012 DBMET02074 | DBMET02073 | |
| 0.116 | 0.012 | 0.165 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.149 0.009 DBMET02073 0.142 0.009 DBMET00531 0.08 0.02 DBMET02074 0.165 0.008 DBMET02075 0.139 0.009 DB12529 | DBMET02075 | |
| 0.148 | 0.049 | 0.525 | Aldehyde dehydrogenase inhibitor | 0.21 0.025 DBMET02073 0.525 0.004 DBMET00531 0.106 0.089 DBMET02074 0.178 0.034 DBMET02075 0.162 0.041 DB12529 | DBMET00531 | |
| 0.103 | 0.005 | 0.12 | Glucose-6-phosphate isomerase inhibitor | 0.12 0.004 DBMET02073 0.111 0.004 DBMET00531 0.074 0.01 DBMET02074 0.117 0.004 DBMET02075 0.105 0.004 DB12529 | DBMET02073 | |
| 0.111 | 0.014 | 0.143 | Ornithine carbamoyltransferase inhibitor | 0.143 0.01 DBMET02073 0.101 0.016 DBMET00531 0.075 0.023 DBMET02074 0.112 0.014 DBMET02075 0.11 0.014 DB12529 | DBMET02073 | |
| 0.127 | 0.031 | 0.35 | Catalase inhibitor | 0.177 0.02 DBMET02073 0.35 0.005 DBMET00531 0.179 0.019 DBMET02075 0.152 0.026 DB12529 | DBMET00531 | |
| 0.099 | 0.005 | 0.141 | Fumarate hydratase inhibitor | 0.141 0.004 DBMET02073 0.086 0.006 DBMET00531 0.098 0.005 DBMET02074 0.076 0.008 DBMET02075 0.091 0.006 DB12529 | DBMET02073 | |
| 0.108 | 0.015 | 0.181 | Acyl-CoA dehydrogenase inhibitor | 0.141 0.01 DBMET02073 0.181 0.006 DBMET00531 0.093 0.018 DBMET02074 0.168 0.007 DBMET02075 0.172 0.007 DB12529 | DBMET00531 | |
| 0.248 | 0.157 | 0.388 | Histamine release inhibitor | 0.362 0.094 DBMET02073 0.37 0.09 DBMET00531 0.357 0.096 DBMET02075 0.388 0.082 DB12529 | DB12529 | |
| 0.167 | 0.078 | 0.196 | Phospholipase C inhibitor | 0.196 0.046 DBMET02073 0.18 0.061 DBMET00531 0.139 0.131 DBMET02074 0.191 0.051 DBMET02075 0.188 0.053 DB12529 | DBMET02073 | |
| 0.098 | 0.009 | 0.999 | Nitric oxide donor | 0.111 0.005 DBMET02073 0.103 0.007 DBMET02074 0.999 0 DB12529 | DB12529 | |
| 0.11 | 0.021 | 0.164 | Phenylalanine 4-hydroxylase inhibitor | 0.149 0.012 DBMET02073 0.141 0.013 DBMET00531 0.064 0.053 DBMET02074 0.164 0.01 DBMET02075 0.132 0.015 DB12529 | DBMET02075 | |
| 0.152 | 0.064 | 0.198 | Cell wall synthesis inhibitor | 0.198 0.031 DBMET02073 0.139 0.076 DBMET00531 0.128 0.088 DBMET02074 0.155 0.061 DBMET02075 0.171 0.046 DB12529 | DBMET02073 | |
| 0.161 | 0.077 | 0.183 | Neurotensin receptor agonist | 0.183 0.046 DBMET02073 0.167 0.067 DBMET00531 0.167 0.067 DBMET02074 0.146 0.113 DBMET02075 0.183 0.047 DB12529 | DB12529 | |
| 0.092 | 0.008 | 0.114 | Alpha-mannosidase inhibitor | 0.114 0.005 DBMET02073 0.077 0.012 DBMET00531 0.066 0.02 DBMET02074 0.097 0.007 DBMET02075 0.084 0.01 DB12529 | DBMET02073 | |
| 0.213 | 0.13 | 0.267 | Gastrin inhibitor | 0.26 0.068 DBMET02073 0.253 0.076 DBMET00531 0.209 0.136 DBMET02074 0.213 0.13 DBMET02075 0.267 0.06 DB12529 | DB12529 | |
| 0.1 | 0.019 | 0.167 | Argininosuccinate synthase inhibitor | 0.137 0.013 DBMET02073 0.157 0.011 DBMET00531 0.103 0.018 DBMET02074 0.114 0.016 DBMET02075 0.167 0.01 DB12529 | DB12529 | |
| 0.147 | 0.068 | 0.185 | Adenylate cyclase stimulant | 0.166 0.04 DBMET02073 0.185 0.022 DBMET00531 0.138 0.084 DBMET02074 0.176 0.029 DBMET02075 0.185 0.022 DB12529 | DB12529 | |
| 0.106 | 0.027 | 0.114 | Na+ K+ transporting ATPase inhibitor | 0.114 0.02 DBMET02073 0.1 0.031 DBMET00531 0.099 0.033 DBMET02074 0.103 0.029 DBMET02075 0.105 0.027 DB12529 | DBMET02073 | |
| 0.102 | 0.024 | 0.137 | Sphingosine 1-phosphate receptor 4 agonist | 0.137 0.011 DBMET02073 0.07 0.044 DBMET00531 0.06 0.055 DBMET02074 0.103 0.023 DBMET02075 0.099 0.026 DB12529 | DBMET02073 | |
| 0.104 | 0.026 | 0.139 | Aminopeptidase I inhibitor | 0.124 0.018 DBMET02073 0.131 0.016 DBMET00531 0.082 0.04 DBMET02074 0.139 0.014 DBMET02075 0.126 0.018 DB12529 | DBMET02075 | |
| 0.181 | 0.103 | 0.268 | 5 Hydroxytryptamine 3E antagonist | 0.2 0.062 DBMET02073 0.262 0.012 DBMET00531 0.21 0.048 DBMET02074 0.206 0.053 DBMET02075 0.268 0.01 DB12529 | DB12529 | |
| 0.123 | 0.049 | 0.235 | GABA C receptor antagonist | 0.156 0.027 DBMET02073 0.235 0.008 DBMET00531 0.134 0.04 DBMET02074 0.177 0.019 DBMET02075 0.232 0.008 DB12529 | DBMET00531 | |
| 0.197 | 0.123 | 0.281 | Interleukin agonist | 0.256 0.075 DBMET02073 0.262 0.07 DBMET00531 0.162 0.156 DBMET02074 0.242 0.084 DBMET02075 0.281 0.058 DB12529 | DB12529 | |
| 0.144 | 0.071 | 0.17 | Sphingosine 1-phosphate receptor 5 antagonist | 0.17 0.034 DBMET02073 0.157 0.05 DBMET00531 0.124 0.115 DBMET02074 0.168 0.036 DBMET02075 0.167 0.037 DB12529 | DBMET02073 | |
| 0.082 | 0.008 | 0.106 | Mannosidase inhibitor | 0.106 0.005 DBMET02073 0.066 0.014 DBMET00531 0.054 0.021 DBMET02074 0.085 0.008 DBMET02075 0.073 0.011 DB12529 | DBMET02073 | |
| 0.113 | 0.044 | 0.157 | HIV-1 integrase (Overall Integration) inhibitor | 0.154 0.024 DBMET02073 0.139 0.03 DBMET00531 0.098 0.056 DBMET02074 0.116 0.042 DBMET02075 0.157 0.023 DB12529 | DB12529 | |
| 0.086 | 0.018 | 0.109 | Glutamate (mGluR6) antagonist | 0.1 0.011 DBMET02073 0.107 0.008 DBMET00531 0.078 0.026 DBMET02074 0.109 0.008 DBMET02075 0.103 0.009 DB12529 | DBMET02075 | |
| 0.081 | 0.013 | 0.144 | Aconitate hydratase inhibitor | 0.102 0.008 DBMET02073 0.144 0.004 DBMET00531 0.073 0.017 DBMET02074 0.098 0.009 DBMET02075 0.127 0.005 DB12529 | DBMET00531 | |
| 0.089 | 0.027 | 0.107 | GABA B receptor agonist | 0.107 0.012 DBMET02073 0.094 0.022 DBMET00531 0.08 0.042 DBMET02074 0.088 0.029 DBMET02075 0.102 0.015 DB12529 | DBMET02073 | |
| 0.094 | 0.033 | 0.117 | Estrogen-related receptor beta agonist | 0.106 0.019 DBMET02073 0.108 0.017 DBMET00531 0.081 0.064 DBMET02074 0.117 0.011 DBMET02075 0.107 0.018 DB12529 | DBMET02075 | |
| 0.085 | 0.025 | 0.109 | NMDA receptor glycine site agonist | 0.109 0.013 DBMET02073 0.08 0.028 DBMET00531 0.07 0.036 DBMET02074 0.077 0.031 DBMET02075 0.097 0.018 DB12529 | DBMET02073 | |
| 0.204 | 0.144 | 0.402 | 5 Hydroxytryptamine uptake stimulant | 0.241 0.089 DBMET02073 0.402 0.014 DBMET00531 0.262 0.07 DBMET02074 0.277 0.058 DBMET02075 0.4 0.014 DB12529 | DBMET00531 | |
| 0.143 | 0.084 | 0.253 | GABA C receptor rho-2 antagonist | 0.172 0.049 DBMET02073 0.253 0.011 DBMET00531 0.163 0.058 DBMET02074 0.191 0.034 DBMET02075 0.248 0.012 DB12529 | DBMET00531 | |
| 0.144 | 0.087 | 0.177 | Interferon gamma antagonist | 0.167 0.06 DBMET02073 0.171 0.056 DBMET00531 0.132 0.106 DBMET02074 0.17 0.057 DBMET02075 0.177 0.052 DB12529 | DB12529 | |
| 0.062 | 0.007 | 0.073 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.073 0.005 DBMET02073 0.047 0.01 DBMET00531 0.052 0.009 DBMET02074 0.045 0.01 DBMET02075 0.054 0.008 DB12529 | DBMET02073 | |
| 0.108 | 0.053 | 0.145 | Anabolic | 0.124 0.036 DBMET02073 0.141 0.023 DBMET00531 0.112 0.048 DBMET02074 0.125 0.035 DBMET02075 0.145 0.021 DB12529 | DB12529 | |
| 0.105 | 0.056 | 0.205 | GABA C receptor rho-1 antagonist | 0.132 0.031 DBMET02073 0.205 0.007 DBMET00531 0.119 0.041 DBMET02074 0.147 0.023 DBMET02075 0.202 0.008 DB12529 | DBMET00531 | |
| 0.057 | 0.009 | 0.075 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.068 0.005 DBMET02073 0.067 0.005 DBMET00531 0.058 0.008 DBMET02074 0.062 0.007 DBMET02075 0.075 0.004 DB12529 | DB12529 | |
| 0.091 | 0.043 | 0.116 | D-Ala-D-Ala ligase inhibitor | 0.103 0.025 DBMET02073 0.108 0.021 DBMET00531 0.1 0.029 DBMET02074 0.091 0.042 DBMET02075 0.116 0.015 DB12529 | DB12529 | |
| 0.056 | 0.008 | 0.076 | Glutamate (mGluR8) agonist | 0.067 0.005 DBMET02073 0.067 0.005 DBMET00531 0.057 0.008 DBMET02074 0.048 0.013 DBMET02075 0.076 0.004 DB12529 | DB12529 | |
| 0.098 | 0.055 | 0.131 | Alcohol dehydrogenase inhibitor | 0.131 0.028 DBMET02073 0.096 0.057 DBMET00531 0.106 0.046 DBMET02075 0.11 0.042 DB12529 | DBMET02073 | |
| 0.119 | 0.076 | 0.175 | Cathepsin H inhibitor | 0.147 0.048 DBMET02073 0.156 0.042 DBMET00531 0.146 0.049 DBMET02074 0.124 0.07 DBMET02075 0.175 0.032 DB12529 | DB12529 | |
| 0.108 | 0.067 | 0.154 | Mucolytic | 0.136 0.041 DBMET02073 0.132 0.045 DBMET00531 0.154 0.03 DBMET02075 0.131 0.045 DB12529 | DBMET02075 | |
| 0.073 | 0.034 | 0.103 | NMDA receptor agonist | 0.103 0.018 DBMET02073 0.074 0.033 DBMET00531 0.061 0.046 DBMET02074 0.067 0.039 DBMET02075 0.092 0.023 DB12529 | DBMET02073 | |
| 0.11 | 0.071 | 0.148 | Photosensitizer | 0.134 0.042 DBMET02073 0.141 0.037 DBMET00531 0.103 0.083 DBMET02074 0.133 0.043 DBMET02075 0.148 0.032 DB12529 | DB12529 | |
| 0.107 | 0.069 | 0.208 | Cystathionine beta-synthase inhibitor | 0.141 0.045 DBMET02073 0.208 0.023 DBMET00531 0.103 0.073 DBMET02074 0.14 0.045 DBMET02075 0.194 0.026 DB12529 | DBMET00531 | |
| 0.051 | 0.013 | 0.067 | Kainate receptor agonist | 0.059 0.007 DBMET02073 0.062 0.006 DBMET00531 0.053 0.011 DBMET02074 0.053 0.011 DBMET02075 0.067 0.005 DB12529 | DB12529 | |
| 0.042 | 0.005 | 0.049 | Estrogen-related receptor gamma antagonist | 0.049 0.004 DBMET02073 0.032 0.013 DBMET00531 0.03 0.015 DBMET02074 0.046 0.004 DBMET02075 0.036 0.007 DB12529 | DBMET02073 | |
| 0.078 | 0.041 | 0.114 | Glycine receptor agonist | 0.097 0.023 DBMET02073 0.114 0.014 DBMET00531 0.066 0.064 DBMET02074 0.114 0.014 DBMET02075 0.111 0.015 DB12529 | DBMET02075 | |
| 0.099 | 0.063 | 0.136 | Carbonic anhydrase III inhibitor | 0.133 0.036 DBMET02073 0.115 0.048 DBMET00531 0.087 0.08 DBMET02074 0.103 0.059 DBMET02075 0.136 0.034 DB12529 | DB12529 | |
| 0.089 | 0.053 | 0.132 | Granulocyte macrophage colony stimulating factor agonist | 0.103 0.031 DBMET02073 0.132 0.01 DBMET00531 0.091 0.05 DBMET02074 0.116 0.019 DBMET02075 0.13 0.011 DB12529 | DBMET00531 | |
| 0.045 | 0.01 | 0.063 | Uridine phosphorylase inhibitor | 0.059 0.006 DBMET02073 0.043 0.01 DBMET00531 0.063 0.005 DBMET02075 0.047 0.009 DB12529 | DBMET02075 | |
| 0.059 | 0.024 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | 0.071 0.014 DBMET02073 0.063 0.019 DBMET00531 0.053 0.032 DBMET02074 0.069 0.015 DBMET02075 0.068 0.015 DB12529 | DBMET02073 | |
| 0.178 | 0.143 | 0.508 | 5 Hydroxytryptamine release stimulant | 0.248 0.09 DBMET02073 0.49 0.029 DBMET00531 0.223 0.104 DBMET02074 0.353 0.056 DBMET02075 0.508 0.026 DB12529 | DB12529 | |
| 0.055 | 0.02 | 0.074 | Fructose-1,6-bisphosphatase inhibitor | 0.074 0.01 DBMET02073 0.054 0.021 DBMET02074 0.04 0.039 DBMET02075 0.053 0.022 DB12529 | DBMET02073 | |
| 0.086 | 0.052 | 0.111 | Glutathione S-transferase inhibitor | 0.111 0.028 DBMET02073 0.078 0.065 DBMET00531 0.083 0.057 DBMET02075 0.095 0.042 DB12529 | DBMET02073 | |
| 0.11 | 0.077 | 0.148 | Interleukin 8 antagonist | 0.148 0.035 DBMET02073 0.107 0.081 DBMET02074 0.112 0.073 DB12529 | DBMET02073 | |
| 0.079 | 0.048 | 0.113 | GABA aminotransferase inhibitor | 0.1 0.027 DBMET02073 0.1 0.027 DBMET00531 0.076 0.052 DBMET02074 0.113 0.019 DBMET02075 0.104 0.024 DB12529 | DBMET02075 | |
| 0.122 | 0.093 | 0.151 | Sphingosine 1-phosphate receptor 2 antagonist | 0.146 0.047 DBMET02073 0.143 0.05 DBMET00531 0.148 0.043 DBMET02075 0.151 0.039 DB12529 | DB12529 | |
| 0.049 | 0.021 | 0.072 | Glutamate (mGluR4) antagonist | 0.072 0.01 DBMET02073 0.046 0.025 DBMET00531 0.045 0.028 DBMET02074 0.044 0.029 DBMET02075 0.058 0.015 DB12529 | DBMET02073 | |
| 0.064 | 0.038 | 0.119 | Purinergic P2X1 antagonist | 0.084 0.023 DBMET02073 0.11 0.014 DBMET00531 0.069 0.033 DBMET02074 0.075 0.028 DBMET02075 0.119 0.012 DB12529 | DB12529 | |
| 0.205 | 0.18 | 0.267 | Interleukin 2 agonist | 0.267 0.101 DBMET02073 0.218 0.16 DBMET02075 | DBMET02073 | |
| 0.077 | 0.055 | 0.098 | MAP kinase kinase 7 inhibitor | 0.087 0.03 DBMET02073 0.09 0.024 DBMET00531 0.098 0.015 DBMET02075 0.091 0.022 DB12529 | DBMET02075 | |
| 0.067 | 0.046 | 0.08 | MDM2 inhibitor | 0.08 0.02 DBMET02073 0.069 0.041 DBMET00531 0.063 0.062 DBMET02074 0.071 0.035 DBMET02075 0.077 0.025 DB12529 | DBMET02073 | |
| 0.065 | 0.044 | 0.082 | Interferon inducer | 0.08 0.024 DBMET02073 0.067 0.039 DBMET00531 0.082 0.022 DBMET02075 0.074 0.03 DB12529 | DBMET02075 | |
| 0.076 | 0.055 | 0.111 | Keratolytic | 0.095 0.034 DBMET02073 0.096 0.033 DBMET00531 0.111 0.025 DBMET02075 0.092 0.036 DB12529 | DBMET02075 | |
| 0.056 | 0.036 | 0.077 | Dihydroorotate oxidase inhibitor | 0.067 0.019 DBMET02073 0.074 0.014 DBMET00531 0.059 0.031 DBMET02074 0.061 0.027 DBMET02075 0.077 0.012 DB12529 | DB12529 | |
| 0.077 | 0.058 | 0.098 | Interferon agonist | 0.096 0.032 DBMET02073 0.081 0.051 DBMET00531 0.098 0.03 DBMET02075 0.088 0.041 DB12529 | DBMET02075 | |
| 0.073 | 0.055 | 0.108 | Vanilloid 4 agonist | 0.086 0.031 DBMET02073 0.101 0.016 DBMET00531 0.084 0.033 DBMET02074 0.083 0.035 DBMET02075 0.108 0.011 DB12529 | DB12529 | |
| 0.029 | 0.011 | 0.042 | Lysophosphatidic acid receptor 1 agonist | 0.035 0.007 DBMET02073 0.032 0.009 DBMET00531 0.042 0.005 DBMET02075 0.032 0.01 DB12529 | DBMET02075 | |
| 0.101 | 0.085 | 0.141 | Cholesterol synthesis inhibitor | 0.128 0.058 DBMET02073 0.124 0.061 DBMET00531 0.141 0.049 DBMET02075 0.129 0.057 DB12529 | DBMET02075 | |
| 0.044 | 0.028 | 0.066 | Guanylate cyclase inhibitor | 0.057 0.014 DBMET02073 0.064 0.008 DBMET00531 0.058 0.013 DBMET02075 0.066 0.007 DB12529 | DB12529 | |
| 0.041 | 0.025 | 0.054 | GABA uptake inhibitor | 0.054 0.013 DBMET02073 0.05 0.016 DBMET00531 0.05 0.015 DBMET02075 0.053 0.014 DB12529 | DBMET02073 | |
| 0.138 | 0.123 | 0.18 | ATPase inhibitor | 0.18 0.058 DBMET02073 0.159 0.087 DBMET00531 0.137 0.127 DBMET02074 0.136 0.128 DBMET02075 0.173 0.067 DB12529 | DBMET02073 | |
| 0.138 | 0.123 | 0.229 | 3C-like protease (Human coronavirus) inhibitor | 0.178 0.067 DBMET02073 0.189 0.059 DBMET00531 0.168 0.076 DBMET02074 0.229 0.037 DB12529 | DB12529 | |
| 0.124 | 0.109 | 0.157 | Thiol protease inhibitor | 0.157 0.063 DBMET02073 0.124 0.108 DBMET02074 0.133 0.09 DB12529 | DBMET02073 | |
| 0.026 | 0.012 | 0.033 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.033 0.006 DBMET02073 0.026 0.011 DBMET02074 0.026 0.012 DB12529 | DBMET02073 | |
| 0.072 | 0.059 | 0.099 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.099 0.038 DBMET02073 0.078 0.053 DBMET00531 0.071 0.06 DBMET02075 0.091 0.043 DB12529 | DBMET02073 | |
| 0.131 | 0.117 | 0.153 | Heat shock protein 70 antagonist | 0.145 0.06 DBMET02073 0.149 0.049 DBMET00531 0.129 0.125 DBMET02074 0.142 0.068 DBMET02075 0.153 0.04 DB12529 | DB12529 | |
| 0.076 | 0.063 | 0.104 | Carbonic anhydrase VI inhibitor | 0.104 0.037 DBMET02073 0.084 0.052 DBMET00531 0.084 0.052 DBMET02075 0.096 0.042 DB12529 | DBMET02073 | |
| 0.028 | 0.015 | 0.034 | Thymidine phosphorylase inhibitor | 0.034 0.009 DBMET02073 0.029 0.014 DBMET00531 0.026 0.018 DBMET02074 0.032 0.01 DBMET02075 0.031 0.011 DB12529 | DBMET02073 | |
| 0.024 | 0.012 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.028 0.007 DBMET02073 0.024 0.013 DBMET00531 0.027 0.008 DBMET02075 0.026 0.01 DB12529 | DBMET02073 | |
| 0.088 | 0.077 | 0.156 | Electrolyte absorption antagonist | 0.113 0.043 DBMET02073 0.156 0.017 DBMET00531 0.095 0.065 DBMET02074 0.127 0.031 DBMET02075 0.155 0.018 DB12529 | DBMET00531 | |
| 0.045 | 0.035 | 0.063 | Adenosine deaminase inhibitor | 0.059 0.022 DBMET02073 0.054 0.026 DBMET00531 0.063 0.018 DBMET02075 0.057 0.024 DB12529 | DBMET02075 | |
| 0.043 | 0.033 | 0.057 | Glutamate (mGluR group III) antagonist | 0.057 0.014 DBMET02073 0.044 0.03 DBMET00531 0.04 0.039 DBMET02074 0.041 0.037 DBMET02075 0.052 0.019 DB12529 | DBMET02073 | |
| 0.105 | 0.095 | 0.161 | Cyclooxygenase 3 inhibitor | 0.138 0.059 DBMET02073 0.143 0.055 DBMET00531 0.141 0.056 DBMET02075 0.161 0.039 DB12529 | DB12529 | |
| 0.032 | 0.022 | 0.039 | Glutamate (mGluR3) agonist | 0.038 0.013 DBMET02073 0.039 0.01 DBMET00531 0.037 0.013 DBMET02075 0.039 0.01 DB12529 | DB12529 | |
| 0.04 | 0.03 | 0.052 | Toll-Like receptor 2 agonist | 0.052 0.023 DBMET02073 0.038 0.031 DBMET00531 0.046 0.026 DBMET02075 0.044 0.026 DB12529 | DBMET02073 | |
| 0.128 | 0.118 | 0.159 | Melanin inhibitor | 0.148 0.084 DBMET02073 0.154 0.076 DBMET00531 0.148 0.084 DBMET02075 0.159 0.071 DB12529 | DB12529 | |
| 0.086 | 0.077 | 0.122 | Sphingomyelinase inhibitor | 0.114 0.046 DBMET02073 0.113 0.047 DBMET00531 0.122 0.04 DBMET02075 0.117 0.044 DB12529 | DBMET02075 | |
| 0.017 | 0.008 | 0.022 | Thromboxane A2 agonist | 0.022 0.005 DBMET02073 0.019 0.007 DBMET00531 0.015 0.012 DBMET02074 0.016 0.011 DBMET02075 0.022 0.005 DB12529 | DB12529 | |
| 0.018 | 0.01 | 0.024 | Telomerase stimulant | 0.021 0.006 DBMET02073 0.024 0.005 DBMET00531 0.019 0.009 DBMET02074 0.024 0.005 DBMET02075 0.024 0.004 DB12529 | DB12529 | |
| 0.032 | 0.024 | 0.042 | Estrogen-related receptor beta antagonist | 0.04 0.011 DBMET02073 0.042 0.009 DBMET02075 | DBMET02075 | |
| 0.033 | 0.026 | 0.045 | Phosphoglycerate kinase inhibitor | 0.045 0.016 DBMET02073 0.037 0.022 DBMET00531 0.043 0.018 DBMET02075 0.043 0.018 DB12529 | DBMET02073 | |
| 0.015 | 0.008 | 0.027 | Lysophosphatidic acid receptor 3 agonist | 0.02 0.005 DBMET02073 0.02 0.005 DBMET00531 0.027 0.004 DBMET02075 0.02 0.005 DB12529 | DBMET02075 | |
| 0.011 | 0.004 | 0.014 | Mannitol 2-dehydrogenase inhibitor | 0.014 0.003 DBMET02073 0.012 0.004 DBMET02075 | DBMET02073 | |
| 0.036 | 0.03 | 0.048 | Potassium channel Kv1.1 blocker | 0.036 0.03 DBMET02073 0.041 0.021 DBMET00531 0.047 0.015 DBMET02074 0.048 0.014 DB12529 | DB12529 | |
| 0.098 | 0.092 | 0.13 | TRPA1 agonist | 0.129 0.049 DBMET02073 0.117 0.062 DBMET00531 0.122 0.056 DBMET02074 0.116 0.064 DBMET02075 0.13 0.048 DB12529 | DB12529 | |
| 0.013 | 0.007 | 0.02 | Glutamate (mGluR6) agonist | 0.017 0.005 DBMET02073 0.017 0.005 DBMET00531 0.013 0.008 DBMET02074 0.02 0.004 DB12529 | DB12529 | |
| 0.086 | 0.08 | 0.133 | Lanosterol 14 alpha demethylase inhibitor | 0.113 0.039 DBMET02073 0.119 0.032 DBMET00531 0.092 0.068 DBMET02074 0.101 0.055 DBMET02075 0.133 0.019 DB12529 | DB12529 | |
| 0.018 | 0.013 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.009 DBMET02073 0.022 0.006 DBMET00531 0.017 0.015 DBMET02074 0.021 0.007 DBMET02075 0.022 0.006 DB12529 | DB12529 | |
| 0.036 | 0.032 | 0.051 | Membrane dipeptidase inhibitor | 0.044 0.021 DBMET02073 0.051 0.015 DBMET00531 0.051 0.015 DBMET02075 0.049 0.016 DB12529 | DBMET02075 | |
| 0.038 | 0.034 | 0.048 | Thymidine kinase inhibitor | 0.047 0.021 DBMET02073 0.044 0.024 DBMET00531 0.048 0.02 DBMET02075 0.045 0.023 DB12529 | DBMET02075 | |
| 0.073 | 0.07 | 0.125 | Glycine receptor antagonist | 0.093 0.04 DBMET02073 0.118 0.019 DBMET00531 0.091 0.041 DBMET02074 0.089 0.044 DBMET02075 0.125 0.015 DB12529 | DB12529 | |
| 0.015 | 0.012 | 0.02 | Purinergic P2Y1 agonist | 0.017 0.009 DBMET02073 0.017 0.008 DBMET00531 0.015 0.012 DBMET02074 0.015 0.011 DBMET02075 0.02 0.007 DB12529 | DB12529 | |
| 0.051 | 0.048 | 0.065 | DNA helicase inhibitor | 0.065 0.021 DBMET02073 | DBMET02073 | |
| 0.025 | 0.023 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 DBMET02073 0.028 0.014 DBMET00531 0.029 0.012 DBMET02075 0.029 0.013 DB12529 | DB12529 | |
| 0.041 | 0.039 | 0.051 | Heme oxygenase inhibitor | 0.046 0.021 DBMET02073 0.047 0.018 DBMET00531 0.045 0.024 DBMET02074 0.051 0.012 DB12529 | DB12529 | |
| 0.063 | 0.062 | 0.125 | Exportin-1 inhibitor | 0.092 0.014 DBMET02073 0.103 0.008 DBMET00531 0.083 0.021 DBMET02074 0.125 0.004 DBMET02075 0.108 0.006 DB12529 | DBMET02075 | |
| 0.015 | 0.014 | 0.033 | Carbonic anhydrase VIII inhibitor | 0.02 0.009 DBMET02073 0.033 0.004 DBMET00531 0.017 0.012 DBMET02074 0.022 0.007 DBMET02075 0.032 0.004 DB12529 | DBMET00531 | |
| 0.015 | 0.014 | 0.033 | Carbonic anhydrase X inhibitor | 0.02 0.009 DBMET02073 0.033 0.004 DBMET00531 0.017 0.012 DBMET02074 0.022 0.007 DBMET02075 0.032 0.004 DB12529 | DBMET00531 | |
| 0.024 | 0.023 | 0.03 | Lysine carboxypeptidase inhibitor | 0.029 0.016 DBMET02073 0.03 0.016 DBMET00531 0.028 0.017 DBMET02075 0.029 0.017 DB12529 | DBMET00531 | |
| 0.02 | 0.02 | 0.028 | Prostaglandin F2 alpha agonist | 0.025 0.013 DBMET02073 0.024 0.014 DBMET00531 0.028 0.01 DBMET02075 0.024 0.014 DB12529 | DBMET02075 | |
| 0.047 | 0.048 | 0.07 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.062 0.028 DBMET02073 0.069 0.022 DBMET00531 0.07 0.022 DBMET02075 0.067 0.024 DB12529 | DBMET02075 | |
| 0.067 | 0.068 | 0.11 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.078 0.04 DBMET02073 0.101 0.013 DBMET00531 0.086 0.028 DBMET02074 0.071 0.057 DBMET02075 0.11 0.009 DB12529 | DB12529 | |
| 0.026 | 0.027 | 0.044 | Purinergic P2Y15 antagonist | 0.031 0.016 DBMET02073 0.044 0.005 DBMET00531 0.03 0.017 DBMET02074 0.033 0.013 DBMET02075 0.044 0.005 DB12529 | DB12529 | |
| 0.065 | 0.066 | 0.099 | Phospholipase D inhibitor | 0.079 0.035 DBMET02073 0.099 0.015 DBMET00531 0.068 0.057 DBMET02074 0.086 0.026 DBMET02075 0.097 0.016 DB12529 | DBMET00531 | |
| 0.086 | 0.087 | 0.132 | Expectorant | 0.112 0.057 DBMET02073 0.103 0.065 DBMET00531 0.132 0.043 DBMET02075 0.102 0.066 DB12529 | DBMET02075 | |
| 0.188 | 0.19 | 0.303 | Vasodilator, peripheral | 0.276 0.11 DBMET02073 0.226 0.148 DBMET00531 0.21 0.165 DBMET02075 0.303 0.095 DB12529 | DB12529 | |
| 0.094 | 0.096 | 0.137 | Alkylator | 0.137 0.054 DBMET02073 0.125 0.063 DBMET02075 0.12 0.068 DB12529 | DBMET02073 | |
| 0.096 | 0.099 | 0.243 | Microtubule formation inhibitor | 0.117 0.064 DBMET02073 0.127 0.053 DBMET00531 0.243 0.01 DBMET02075 0.136 0.046 DB12529 | DBMET02075 | |
| 0.018 | 0.022 | 0.023 | Retinoid X beta receptor antagonist | 0.021 0.013 DBMET02073 0.022 0.011 DBMET00531 0.023 0.009 DBMET02075 0.022 0.011 DB12529 | DBMET02075 | |
| 0.016 | 0.022 | 0.021 | Antibiotic Anthracycline-like | 0.019 0.012 DBMET02073 0.021 0.01 DBMET00531 0.021 0.009 DBMET02075 0.021 0.009 DB12529 | DB12529 | |
| 0.086 | 0.091 | 0.134 | Carbonic anhydrase XV inhibitor | 0.108 0.057 DBMET02073 0.134 0.038 DBMET00531 0.119 0.048 DBMET02075 0.13 0.04 DB12529 | DBMET00531 | |
| 0.051 | 0.058 | 0.076 | Pregnane X receptor antagonist | 0.06 0.03 DBMET02073 0.073 0.011 DBMET00531 0.065 0.02 DBMET02075 0.076 0.009 DB12529 | DB12529 | |
| 0.054 | 0.061 | 0.075 | Ryanodine receptor antagonist | 0.062 0.032 DBMET02073 0.069 0.018 DBMET00531 0.062 0.033 DBMET02074 0.075 0.012 DB12529 | DB12529 | |
| 0.028 | 0.035 | 0.039 | Retinoid X alpha receptor agonist | 0.039 0.02 DBMET02073 0.034 0.025 DBMET00531 0.032 0.028 DBMET02075 0.035 0.024 DB12529 | DBMET02073 | |
| 0.007 | 0.015 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 DB12529 | DB12529 | |
| 0.009 | 0.018 | 0.017 | Carbonic anhydrase XI inhibitor | 0.012 0.01 DBMET02073 0.016 0.005 DBMET00531 0.012 0.01 DBMET02074 0.017 0.005 DB12529 | DB12529 | |
| 0.098 | 0.107 | 0.151 | Toll-Like receptor 2 antagonist | 0.128 0.07 DBMET02073 0.14 0.059 DBMET00531 0.151 0.052 DBMET02075 0.137 0.062 DB12529 | DBMET02075 | |
| 0.109 | 0.118 | 0.133 | Vanilloid 1 agonist | 0.125 0.076 DBMET02073 0.129 0.068 DBMET00531 0.128 0.07 DBMET02075 0.133 0.061 DB12529 | DB12529 | |
| 0.007 | 0.016 | 0.01 | Thromboxane agonist | 0.01 0.009 DB12529 | DB12529 | |
| 0.045 | 0.055 | 0.066 | Beta 1 adrenoreceptor antagonist | 0.066 0.029 DBMET02073 | DBMET02073 | |
| 0.021 | 0.032 | 0.035 | Vanilloid 2 agonist | 0.024 0.02 DBMET02073 0.035 0.006 DBMET00531 0.024 0.02 DBMET02074 0.028 0.013 DBMET02075 0.035 0.005 DB12529 | DB12529 | |
| 0.031 | 0.042 | 0.056 | Dihydropteroate synthase inhibitor | 0.042 0.024 DBMET02073 0.043 0.023 DBMET00531 0.056 0.013 DB12529 | DB12529 | |
| 0.02 | 0.032 | 0.03 | Glutamate (mGluR1) agonist | 0.026 0.015 DBMET02073 0.026 0.014 DBMET00531 0.03 0.009 DB12529 | DB12529 | |
| 0.021 | 0.033 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.018 DBMET02073 0.026 0.019 DBMET02075 0.025 0.02 DB12529 | DBMET02075 | |
| 0.014 | 0.027 | 0.021 | Estrogen-related receptor gamma agonist | 0.017 0.016 DBMET02073 0.021 0.009 DBMET02075 | DBMET02075 | |
| 0.017 | 0.03 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.015 DBMET02073 0.023 0.01 DBMET00531 0.021 0.013 DBMET02075 0.023 0.01 DB12529 | DB12529 | |
| 0.085 | 0.099 | 0.107 | Beta glucuronidase inhibitor | 0.107 0.06 DBMET02073 0.103 0.066 DB12529 | DBMET02073 | |
| 0.045 | 0.059 | 0.065 | Nicotinic alpha3beta2 receptor antagonist | 0.057 0.031 DBMET02073 0.056 0.032 DBMET00531 0.049 0.045 DBMET02075 0.065 0.021 DB12529 | DB12529 | |
| 0.052 | 0.066 | 0.096 | Acetylcholine M5 receptor agonist | 0.078 0.036 DBMET02073 0.094 0.023 DBMET00531 0.072 0.041 DBMET02074 0.096 0.023 DB12529 | DB12529 | |
| 0.017 | 0.031 | 0.023 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 DBMET02073 0.023 0.011 DBMET00531 0.023 0.011 DBMET02075 0.023 0.011 DB12529 | DB12529 | |
| 0.046 | 0.06 | 0.062 | Glucosylceramidase inhibitor | 0.062 0.029 DBMET02073 0.062 0.029 DBMET02075 0.055 0.038 DB12529 | DBMET02075 | |
| 0.114 | 0.129 | 0.158 | Hexokinase inhibitor | 0.158 0.07 DBMET02073 0.142 0.088 DBMET00531 0.141 0.09 DBMET02075 0.155 0.073 DB12529 | DBMET02073 | |
| 0.103 | 0.119 | 0.13 | DNA repair enzyme inhibitor | 0.126 0.062 DBMET02073 0.114 0.085 DBMET00531 0.13 0.055 DB12529 | DB12529 | |
| 0.023 | 0.04 | 0.03 | Calcitonin receptor agonist | 0.029 0.028 DBMET00531 0.03 0.026 DBMET02075 0.03 0.027 DB12529 | DB12529 | |
| 0.078 | 0.095 | 0.111 | MAP kinase kinase 1 inhibitor | 0.111 0.044 DBMET02073 0.102 0.055 DBMET02075 0.094 0.064 DB12529 | DBMET02073 | |
| 0.022 | 0.04 | 0.045 | Arginase inhibitor | 0.036 0.026 DBMET02073 0.045 0.018 DBMET00531 0.039 0.023 DBMET02075 0.044 0.019 DB12529 | DBMET00531 | |
| 0.028 | 0.046 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.036 0.024 DBMET02073 0.033 0.029 DBMET00531 0.038 0.021 DBMET02075 0.034 0.028 DB12529 | DBMET02075 | |
| 0.03 | 0.048 | 0.076 | Dopamine D5 agonist | 0.038 0.03 DBMET02073 0.071 0.008 DBMET00531 0.042 0.025 DBMET02074 0.042 0.025 DBMET02075 0.076 0.007 DB12529 | DB12529 | |
| 0.052 | 0.071 | 0.07 | Beta adrenoreceptor antagonist | 0.07 0.038 DBMET02073 | DBMET02073 | |
| 0.035 | 0.054 | 0.04 | CF transmembrane conductance regulator antagonist | 0.04 0.027 DBMET02073 0.038 0.034 DBMET00531 0.04 0.026 DB12529 | DB12529 | |
| 0.031 | 0.051 | 0.042 | AMPA 4 receptor antagonist | 0.04 0.027 DBMET02073 0.042 0.023 DB12529 | DB12529 | |
| 0.042 | 0.062 | 0.049 | CD45 antagonist | 0.049 0.038 DBMET02073 0.048 0.04 DB12529 | DBMET02073 | |
| 0.004 | 0.025 | 0.006 | Integrin alpha5beta6 antagonist | 0.006 0.005 DB12529 | DB12529 | |
| 0.022 | 0.043 | 0.04 | Kainate receptor 2 antagonist | 0.04 0.022 DBMET02073 0.039 0.023 DB12529 | DBMET02073 | |
| 0.037 | 0.059 | 0.075 | Carbonic anhydrase VB inhibitor | 0.062 0.033 DBMET02073 0.062 0.033 DBMET00531 0.049 0.046 DBMET02075 0.075 0.025 DB12529 | DB12529 | |
| 0.034 | 0.056 | 0.057 | AICAR transformylase inhibitor | 0.042 0.034 DBMET02073 0.048 0.024 DBMET00531 0.057 0.016 DB12529 | DB12529 | |
| 0.04 | 0.062 | 0.059 | Squalene epoxidase inhibitor | 0.049 0.037 DBMET02073 0.056 0.025 DBMET00531 0.058 0.022 DBMET02075 0.059 0.021 DB12529 | DB12529 | |
| 0.021 | 0.043 | 0.034 | Retinoid X receptor agonist | 0.034 0.026 DBMET02073 0.03 0.029 DB12529 | DBMET02073 | |
| 0.031 | 0.054 | 0.068 | Histamine H2 receptor agonist | 0.041 0.032 DBMET02073 0.063 0.013 DBMET00531 0.056 0.017 DBMET02074 0.068 0.011 DB12529 | DB12529 | |
| 0.074 | 0.097 | 0.109 | Urease inhibitor | 0.108 0.058 DBMET02073 0.088 0.081 DBMET00531 0.109 0.057 DB12529 | DB12529 | |
| 0.1 | 0.123 | 0.142 | Protein kinase stimulant | 0.135 0.08 DBMET02073 0.128 0.085 DBMET00531 0.133 0.081 DBMET02075 0.142 0.074 DB12529 | DB12529 | |
| 0.045 | 0.068 | 0.11 | Androgen agonist | 0.063 0.037 DBMET02073 0.058 0.044 DBMET00531 0.11 0.012 DBMET02075 0.07 0.031 DB12529 | DBMET02075 | |
| 0.054 | 0.078 | 0.086 | Carbonic anhydrase XIII inhibitor | 0.083 0.047 DBMET02073 0.07 0.058 DBMET00531 0.086 0.046 DB12529 | DB12529 | |
| 0.054 | 0.078 | 0.065 | Beta 3 adrenoreceptor antagonist | 0.065 0.044 DBMET02073 0.061 0.054 DBMET02075 | DBMET02073 | |
| 0.02 | 0.045 | 0.034 | Complement factor 1s inhibitor | 0.024 0.023 DBMET02073 0.03 0.008 DBMET00531 0.028 0.011 DBMET02074 0.034 0.005 DB12529 | DB12529 | |
| 0.072 | 0.096 | 0.148 | Prolactin inhibitor | 0.095 0.06 DBMET02073 0.145 0.024 DBMET00531 0.082 0.078 DBMET02074 0.116 0.041 DBMET02075 0.148 0.023 DB12529 | DB12529 | |
| 0.004 | 0.029 | 0.009 | Progesterone receptor A antagonist | 0.009 0.007 DB12529 | DB12529 | |
| 0.044 | 0.069 | 0.058 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.058 0.042 DBMET02073 0.054 0.047 DBMET02075 0.057 0.042 DB12529 | DBMET02073 | |
| 0.043 | 0.068 | 0.065 | Sphingosine kinase 2 inhibitor | 0.056 0.036 DBMET02073 0.058 0.034 DBMET00531 0.065 0.026 DBMET02075 0.063 0.028 DB12529 | DBMET02075 | |
| 0.048 | 0.073 | 0.066 | Immunoglobulin Fc receptor antagonist | 0.055 0.04 DBMET02073 0.064 0.017 DBMET00531 0.056 0.034 DBMET02075 0.066 0.015 DB12529 | DB12529 | |
| 0.034 | 0.059 | 0.078 | Adenylate cyclase 1 inhibitor | 0.048 0.029 DBMET02073 0.078 0.009 DBMET00531 0.057 0.02 DBMET02075 0.077 0.009 DB12529 | DBMET00531 | |
| 0.018 | 0.044 | 0.034 | Nicotinic acid receptor 2 antagonist | 0.024 0.023 DBMET02073 0.034 0.009 DBMET00531 0.027 0.018 DBMET02075 0.034 0.009 DB12529 | DB12529 | |
| 0.055 | 0.081 | 0.104 | Glutamate (mGluR7) antagonist | 0.068 0.046 DBMET02073 0.104 0.009 DBMET00531 0.073 0.037 DBMET02074 0.071 0.04 DBMET02075 0.102 0.01 DB12529 | DBMET00531 | |
| 0.004 | 0.03 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.004 DBMET00531 0.008 0.004 DB12529 | DB12529 | |
| 0.022 | 0.048 | 0.034 | Hedgehog signaling activator | 0.033 0.009 DBMET00531 0.027 0.019 DBMET02075 0.034 0.008 DB12529 | DB12529 | |
| 0.032 | 0.058 | 0.057 | Geranyltranstransferase inhibitor | 0.043 0.032 DBMET02073 0.055 0.018 DBMET00531 0.052 0.02 DBMET02075 0.057 0.016 DB12529 | DB12529 | |
| 0.218 | 0.245 | 0.342 | Calcium channel L-type activator | 0.342 0.123 DBMET02073 | DBMET02073 | |
| 0.026 | 0.053 | 0.041 | Glutamate (mGluR3) antagonist | 0.036 0.027 DBMET02073 0.041 0.02 DBMET00531 0.034 0.029 DBMET02075 0.041 0.02 DB12529 | DB12529 | |
| 0.021 | 0.048 | 0.037 | Lysophosphatidic acid 2 receptor antagonist | 0.028 0.025 DBMET02073 0.028 0.026 DBMET00531 0.037 0.015 DBMET02075 0.028 0.024 DB12529 | DBMET02075 | |
| 0.035 | 0.062 | 0.051 | Beta 2 adrenoreceptor antagonist | 0.051 0.034 DBMET02073 | DBMET02073 | |
| 0.014 | 0.042 | 0.039 | Glutamate (mGluR1a) agonist | 0.039 0.006 DBMET00531 0.02 0.018 DBMET02075 0.036 0.007 DB12529 | DBMET00531 | |
| 0.025 | 0.054 | 0.035 | Retinoid X alpha receptor antagonist | 0.035 0.023 DBMET00531 0.035 0.021 DBMET02075 0.035 0.023 DB12529 | DB12529 | |
| 0.018 | 0.048 | 0.026 | NMDA 2D receptor antagonist | 0.026 0.02 DBMET02073 | DBMET02073 | |
| 0.05 | 0.08 | 0.077 | Carbonic anhydrase VA inhibitor | 0.069 0.047 DBMET02073 0.066 0.051 DBMET00531 0.077 0.039 DB12529 | DB12529 | |
| 0.028 | 0.059 | 0.04 | Retinoid X receptor antagonist | 0.039 0.025 DBMET00531 0.04 0.024 DBMET02075 0.039 0.025 DB12529 | DBMET02075 | |
| 0.055 | 0.087 | 0.075 | Calcium channel P-type blocker | 0.063 0.047 DBMET02073 0.068 0.033 DBMET00531 0.075 0.02 DB12529 | DB12529 | |
| 0.018 | 0.05 | 0.028 | Integrin alpha2beta1 antagonist | 0.025 0.022 DBMET00531 0.028 0.015 DB12529 | DB12529 | |
| 0.053 | 0.085 | 0.079 | Transcription factor RelA inhibitor | 0.06 0.055 DBMET02073 0.071 0.028 DBMET00531 0.068 0.033 DBMET02074 0.079 0.018 DB12529 | DB12529 | |
| 0.058 | 0.09 | 0.116 | Calcium antagonist | 0.093 0.053 DBMET02073 0.082 0.062 DBMET00531 0.116 0.037 DB12529 | DB12529 | |
| 0.133 | 0.166 | 0.216 | Neurotrophic factor enhancer | 0.171 0.109 DBMET02073 0.216 0.062 DBMET00531 0.199 0.078 DBMET02075 0.213 0.065 DB12529 | DBMET00531 | |
| 0.025 | 0.059 | 0.033 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.033 0.032 DBMET02075 | DBMET02075 | |
| 0.026 | 0.06 | 0.04 | Integrin alpha2 antagonist | 0.034 0.031 DBMET00531 0.04 0.021 DB12529 | DB12529 | |
| 0.049 | 0.083 | 0.077 | Protease 3C (Human rhinovirus) inhibitor | 0.06 0.053 DBMET02073 0.074 0.033 DBMET00531 0.062 0.048 DBMET02075 0.077 0.029 DB12529 | DB12529 | |
| 0.037 | 0.072 | 0.049 | Bombesin 2 receptor antagonist | 0.049 0.034 DB12529 | DB12529 | |
| 0.018 | 0.054 | 0.03 | Acid ceramidase inhibitor | 0.028 0.012 DBMET00531 0.03 0.009 DB12529 | DB12529 | |
| 0.029 | 0.066 | 0.049 | Thymidylate synthase inhibitor | 0.045 0.035 DBMET02073 0.049 0.029 DB12529 | DB12529 | |
| 0.007 | 0.045 | 0.018 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.018 0.005 DBMET00531 0.017 0.005 DB12529 | DBMET00531 | |
| 0.043 | 0.082 | 0.073 | Carbonic anhydrase V inhibitor | 0.064 0.048 DBMET02073 0.06 0.054 DBMET00531 0.073 0.04 DB12529 | DB12529 | |
| 0.024 | 0.063 | 0.054 | Oxytocin agonist | 0.052 0.022 DBMET00531 0.037 0.035 DBMET02075 0.054 0.021 DB12529 | DB12529 | |
| 0.02 | 0.059 | 0.031 | Catechol O-methyltransferase inhibitor | 0.031 0.026 DBMET02073 | DBMET02073 | |
| 0.012 | 0.051 | 0.017 | CXC chemokine 5 receptor antagonist | 0.017 0.015 DB12529 | DB12529 | |
| 0.116 | 0.156 | 0.193 | CF transmembrane conductance regulator agonist | 0.143 0.088 DBMET02073 0.174 0.043 DBMET00531 0.137 0.103 DBMET02074 0.193 0.026 DB12529 | DB12529 | |
| 0.04 | 0.08 | 0.061 | NMDA 2C receptor antagonist | 0.061 0.043 DBMET02073 0.061 0.044 DB12529 | DB12529 | |
| 0.056 | 0.098 | 0.096 | Ornithine decarboxylase inhibitor | 0.082 0.065 DBMET02073 0.096 0.048 DBMET00531 0.096 0.049 DBMET02075 0.095 0.05 DB12529 | DBMET02075 | |
| 0.019 | 0.061 | 0.034 | Free fatty acid receptor 1 antagonist | 0.031 0.027 DBMET00531 0.034 0.023 DB12529 | DB12529 | |
| 0.008 | 0.05 | 0.021 | Cyclin T1 inhibitor | 0.016 0.015 DBMET00531 0.021 0.01 DB12529 | DB12529 | |
| 0.008 | 0.053 | 0.013 | Cyclin D2 inhibitor | 0.013 0.01 DBMET00531 0.013 0.01 DB12529 | DB12529 | |
| 0.142 | 0.187 | 0.216 | DNA damaging | 0.216 0.103 DBMET02073 0.174 0.141 DB12529 | DBMET02073 | |
| 0.027 | 0.073 | 0.038 | Adenosine uptake inhibitor | 0.034 0.026 DBMET00531 0.038 0.016 DB12529 | DB12529 | |
| 0.072 | 0.118 | 0.253 | Xanthine oxidase inhibitor | 0.089 0.073 DBMET02073 0.253 0.012 DBMET00531 0.085 0.08 DB12529 | DBMET00531 | |
| 0.029 | 0.075 | 0.061 | Nerve growth factor antagonist | 0.054 0.014 DBMET00531 0.042 0.032 DBMET02074 0.061 0.009 DB12529 | DB12529 | |
| 0.034 | 0.081 | 0.061 | Potassium channel (ATP-sensitive) activator | 0.045 0.041 DBMET02073 0.052 0.027 DBMET00531 0.047 0.035 DBMET02074 0.061 0.015 DB12529 | DB12529 | |
| 0.036 | 0.083 | 0.064 | Potassium channel (Inward rectifier) activator | 0.047 0.042 DBMET02073 0.055 0.027 DBMET00531 0.05 0.037 DBMET02074 0.064 0.016 DB12529 | DB12529 | |
| 0.014 | 0.061 | 0.036 | Nicotinic alpha4beta2 receptor agonist | 0.033 0.014 DBMET00531 0.036 0.011 DB12529 | DB12529 | |
| 0.03 | 0.078 | 0.049 | Xanthine dehydrogenase inhibitor | 0.049 0.047 DBMET02073 | DBMET02073 | |
| 0.008 | 0.058 | 0.019 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 DBMET00531 0.019 0.01 DB12529 | DB12529 | |
| 0.046 | 0.095 | 0.055 | Leukotriene C antagonist | 0.055 0.045 DBMET00531 0.054 0.046 DBMET02075 0.055 0.045 DB12529 | DB12529 | |
| 0.018 | 0.069 | 0.084 | Kainate receptor antagonist | 0.084 0.009 DB12529 | DB12529 | |
| 0.013 | 0.065 | 0.023 | Factor XIII inhibitor | 0.021 0.014 DBMET00531 0.023 0.01 DB12529 | DB12529 | |
| 0.03 | 0.082 | 0.044 | GABA B receptor antagonist | 0.044 0.028 DB12529 | DB12529 | |
| 0.037 | 0.089 | 0.051 | Heparanase inhibitor | 0.05 0.045 DBMET00531 0.051 0.041 DB12529 | DB12529 | |
| 0.066 | 0.12 | 0.102 | mTOR complex 2 inhibitor | 0.08 0.069 DBMET02073 0.098 0.035 DBMET00531 0.087 0.052 DBMET02075 0.102 0.031 DB12529 | DB12529 | |
| 0.008 | 0.064 | 0.016 | Nicotinic alpha4 receptor agonist | 0.016 0.012 DB12529 | DB12529 | |
| 0.018 | 0.074 | 0.029 | ATP citrate lysase inhibitor | 0.029 0.026 DBMET00531 0.029 0.027 DB12529 | DB12529 | |
| 0.082 | 0.139 | 0.143 | Acetylcholine release stimulant | 0.105 0.077 DBMET02073 0.129 0.036 DBMET00531 0.097 0.095 DBMET02074 0.143 0.021 DB12529 | DB12529 | |
| 0.028 | 0.086 | 0.042 | Vanilloid 3 antagonist | 0.042 0.018 DBMET00531 0.037 0.03 DBMET02075 0.042 0.018 DB12529 | DB12529 | |
| 0.022 | 0.081 | 0.033 | Glutamate (mGluR4) agonist | 0.033 0.025 DB12529 | DB12529 | |
| 0.123 | 0.183 | 0.209 | Immunostimulant | 0.181 0.132 DBMET02073 0.209 0.115 DBMET02075 0.167 0.141 DB12529 | DBMET02075 | |
| 0.023 | 0.085 | 0.034 | Protein kinase (CK2) beta inhibitor | 0.033 0.024 DBMET00531 0.034 0.021 DB12529 | DB12529 | |
| 0.069 | 0.13 | 0.097 | Bile acid receptor antagonist | 0.089 0.077 DBMET02073 0.091 0.072 DBMET00531 0.088 0.08 DBMET02075 0.097 0.057 DB12529 | DB12529 | |
| 0.148 | 0.21 | 0.214 | 12-Lipoxygenase inhibitor | 0.214 0.136 DBMET02073 | DBMET02073 | |
| 0.09 | 0.152 | 0.122 | Antibacterial (Helicobacter pylori) | 0.122 0.078 DBMET02073 0.112 0.094 DB12529 | DBMET02073 | |
| 0.109 | 0.172 | 0.132 | MAP kinase 3 inhibitor | 0.131 0.106 DBMET02073 0.125 0.121 DBMET00531 0.132 0.103 DB12529 | DB12529 | |
| 0.01 | 0.073 | 0.016 | CC chemokine 9 receptor antagonist | 0.016 0.013 DB12529 | DB12529 | |
| 0.033 | 0.096 | 0.071 | Dopamine beta hydroxylase inhibitor | 0.059 0.017 DBMET00531 0.071 0.008 DBMET02075 0.062 0.013 DB12529 | DBMET02075 | |
| 0.034 | 0.099 | 0.053 | Cytokine production stimulant | 0.051 0.027 DBMET00531 0.049 0.033 DBMET02075 0.053 0.022 DB12529 | DB12529 | |
| 0.052 | 0.117 | 0.122 | Histamine N-methyltransferase inhibitor | 0.075 0.073 DBMET02073 0.112 0.035 DBMET00531 0.122 0.028 DB12529 | DB12529 | |
| 0.035 | 0.1 | 0.055 | Sphingosine 1-phosphate receptor 3 antagonist | 0.052 0.051 DBMET02075 0.055 0.046 DB12529 | DB12529 | |
| 0.07 | 0.136 | 0.125 | Glutamate release inhibitor | 0.084 0.078 DBMET02073 0.124 0.019 DBMET00531 0.093 0.055 DBMET02075 0.125 0.019 DB12529 | DB12529 | |
| 0.039 | 0.108 | 0.06 | Sphingosine kinase inhibitor | 0.06 0.039 DBMET02075 0.055 0.049 DB12529 | DBMET02075 | |
| 0.013 | 0.083 | 0.041 | Nicotinic alpha3beta4 receptor agonist | 0.039 0.011 DBMET00531 0.029 0.022 DBMET02074 0.041 0.009 DB12529 | DB12529 | |
| 0.025 | 0.096 | 0.038 | Sphingosine kinase 1 inhibitor | 0.038 0.035 DBMET02075 | DBMET02075 | |
| 0.16 | 0.235 | 0.222 | Antithrombotic | 0.222 0.151 DBMET02073 0.207 0.169 DB12529 | DBMET02073 | |
| 0.049 | 0.124 | 0.089 | Potassium channel (Ca-activated) activator | 0.089 0.066 DBMET02073 0.082 0.073 DB12529 | DBMET02073 | |
| 0.016 | 0.092 | 0.031 | MAP3K8 inhibitor | 0.028 0.024 DBMET00531 0.031 0.016 DB12529 | DB12529 | |
| 0.013 | 0.092 | 0.032 | Methionyl aminopeptidase 1 inhibitor | 0.032 0.023 DB12529 | DB12529 | |
| 0.015 | 0.095 | 0.034 | Epoxide hydrolase 1 inhibitor | 0.033 0.018 DBMET00531 0.034 0.016 DB12529 | DB12529 | |
| 0.125 | 0.206 | 0.192 | Cyclic AMP phosphodiesterase inhibitor | 0.171 0.121 DBMET02073 0.17 0.122 DBMET00531 0.156 0.142 DBMET02075 0.192 0.1 DB12529 | DB12529 | |
| 0.009 | 0.09 | 0.58 | Corticosteroid-like | 0.58 0 DB12529 | DB12529 | |
| 0.099 | 0.182 | 0.292 | DNA methyltransferase I inhibitor | 0.147 0.107 DBMET02073 0.292 0.029 DBMET02075 0.145 0.11 DB12529 | DBMET02075 | |
| 0.029 | 0.112 | 0.052 | Aldosterone antagonist | 0.048 0.032 DBMET00531 0.052 0.027 DB12529 | DB12529 | |
| 0.02 | 0.104 | 0.033 | Melatonin receptor 1A agonist | 0.033 0.024 DBMET00531 0.033 0.025 DB12529 | DB12529 | |
| 0.088 | 0.173 | 0.188 | Phospholipase A2 inhibitor | 0.125 0.109 DBMET02073 0.188 0.05 DBMET02075 | DBMET02075 | |
| 0.054 | 0.139 | 0.079 | Histamine H2 receptor antagonist | 0.079 0.068 DB12529 | DB12529 | |
| 0.155 | 0.24 | 0.279 | Insulysin inhibitor | 0.199 0.158 DBMET02073 0.274 0.076 DBMET00531 0.204 0.151 DBMET02075 0.279 0.073 DB12529 | DB12529 | |
| 0.024 | 0.109 | 0.043 | Glutamate (mGluR group III) agonist | 0.043 0.03 DB12529 | DB12529 | |
| 0.01 | 0.096 | 0.028 | Endothelial nitric-oxide synthase inhibitor | 0.028 0.026 DB12529 | DB12529 | |
| 0.032 | 0.118 | 0.066 | Carbonic anhydrase stimulant | 0.066 0.035 DBMET00531 0.066 0.035 DB12529 | DB12529 | |
| 0.061 | 0.15 | 0.08 | Thioredoxin reductase inhibitor | 0.08 0.062 DBMET02073 | DBMET02073 | |
| 0.002 | 0.092 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 DB12529 | DB12529 | |
| 0.103 | 0.199 | 0.162 | Insulin sensitizer | 0.153 0.129 DBMET02073 0.151 0.132 DBMET00531 0.158 0.123 DBMET02075 0.162 0.117 DB12529 | DB12529 | |
| 0.052 | 0.152 | 0.126 | Falcipain 3 inhibitor | 0.126 0.05 DBMET00531 0.096 0.074 DBMET02075 0.126 0.05 DB12529 | DB12529 | |
| 0.039 | 0.14 | 0.127 | CYP2A6 inhibitor | 0.111 0.031 DBMET00531 0.073 0.055 DBMET02074 0.127 0.024 DB12529 | DB12529 | |
| 0.032 | 0.133 | 0.056 | Botulinum neurotoxin type A inhibitor | 0.056 0.043 DB12529 | DB12529 | |
| 0.072 | 0.173 | 0.107 | Alkaline phosphatase inhibitor | 0.107 0.105 DB12529 | DB12529 | |
| 0.101 | 0.202 | 0.152 | Pregnane X receptor agonist | 0.123 0.119 DBMET02073 0.142 0.069 DBMET00531 0.152 0.05 DB12529 | DB12529 | |
| 0.066 | 0.168 | 0.102 | Caspase 3 inhibitor | 0.098 0.095 DBMET02073 0.102 0.089 DB12529 | DB12529 | |
| 0.102 | 0.206 | 0.179 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.159 0.132 DBMET02073 0.179 0.114 DB12529 | DB12529 | |
| 0.038 | 0.144 | 0.06 | Aryl hydrocarbon receptor antagonist | 0.059 0.056 DBMET00531 0.06 0.054 DB12529 | DB12529 | |
| 0.021 | 0.127 | 0.042 | Dihydroorotase inhibitor | 0.042 0.035 DBMET00531 0.041 0.037 DB12529 | DBMET00531 | |
| 0.009 | 0.116 | 0.024 | Protease (Human cytomegalovirus) inhibitor | 0.021 0.017 DBMET00531 0.024 0.012 DB12529 | DB12529 | |
| 0.031 | 0.138 | 0.057 | Epithelial sodium channel blocker | 0.056 0.035 DBMET00531 0.057 0.033 DB12529 | DB12529 | |
| 0.01 | 0.118 | 0.046 | Peroxisome proliferator-activated receptor delta agonist | 0.046 0.014 DBMET02075 | DBMET02075 | |
| 0.005 | 0.113 | 0.084 | Human T-cell leukemia virus type I protease inhibitor | 0.084 0.003 DBMET02075 | DBMET02075 | |
| 0.029 | 0.137 | 0.048 | Topoisomerase II beta inhibitor | 0.048 0.037 DBMET00531 0.047 0.038 DB12529 | DBMET00531 | |
| 0.005 | 0.114 | 0.018 | Alpha 2a adrenoreceptor agonist | 0.018 0.011 DB12529 | DB12529 | |
| 0.066 | 0.176 | 0.121 | Glutamate (mGluR7) agonist | 0.121 0.03 DBMET00531 0.119 0.031 DB12529 | DBMET00531 | |
| 0.023 | 0.133 | 0.056 | Histamine H1 receptor agonist | 0.054 0.013 DBMET00531 0.043 0.032 DBMET02074 0.056 0.012 DB12529 | DB12529 | |
| 0.016 | 0.127 | 0.039 | Angiotensin AT1 receptor antagonist | 0.039 0.036 DBMET02075 0.039 0.035 DB12529 | DB12529 | |
| 0.015 | 0.128 | 0.07 | Alpha 1d adrenoreceptor agonist | 0.062 0.01 DBMET00531 0.07 0.007 DB12529 | DB12529 | |
| 0.02 | 0.134 | 0.038 | Tryptophan 5 hydroxylase inhibitor | 0.037 0.022 DBMET00531 0.038 0.02 DB12529 | DB12529 | |
| 0.034 | 0.149 | 0.072 | 5 Hydroxytryptamine 3 agonist | 0.069 0.037 DBMET00531 0.072 0.034 DB12529 | DB12529 | |
| 0.057 | 0.177 | 0.1 | Adenylate cyclase inhibitor | 0.096 0.088 DBMET00531 0.1 0.085 DB12529 | DB12529 | |
| 0.01 | 0.131 | 0.039 | Diamine oxidase inhibitor | 0.034 0.031 DBMET00531 0.039 0.024 DB12529 | DB12529 | |
| 0.067 | 0.187 | 0.107 | Toll-Like receptor 9 antagonist | 0.107 0.101 DB12529 | DB12529 | |
| 0.078 | 0.201 | 0.122 | Transcription factor STAT6 inhibitor | 0.111 0.077 DBMET00531 0.122 0.057 DB12529 | DB12529 | |
| 0.108 | 0.232 | 1 | Vasodilator | 0.29 0.052 DBMET02073 1 0 DB12529 | DB12529 | |
| 0.028 | 0.152 | 0.058 | Cyclin D1 inhibitor | 0.055 0.051 DBMET00531 0.058 0.047 DB12529 | DB12529 | |
| 0.034 | 0.159 | 0.076 | Potassium channel intermediate-conductance Ca-activated blocker | 0.066 0.031 DBMET00531 0.076 0.02 DB12529 | DB12529 | |
| 0.011 | 0.137 | 0.036 | Vascular adhesion protein 1 inhibitor | 0.036 0.031 DB12529 | DB12529 | |
| 0.067 | 0.195 | 0.142 | Cytidine deaminase inhibitor | 0.114 0.108 DBMET02073 0.142 0.082 DB12529 | DB12529 | |
| 0.025 | 0.153 | 0.046 | Purinergic P2X4 antagonist | 0.042 0.041 DBMET00531 0.046 0.032 DB12529 | DB12529 | |
| 0.072 | 0.203 | 0.161 | Angiogenesis stimulant | 0.161 0.116 DBMET02073 | DBMET02073 | |
| 0.009 | 0.141 | 0.139 | 5-Alpha-reductase inhibitor | 0.139 0.007 DBMET00531 | DBMET00531 | |
| 0.024 | 0.157 | 0.06 | Cyclin-dependent kinase 6 inhibitor | 0.06 0.041 DB12529 | DB12529 | |
| 0.088 | 0.223 | 0.276 | DNA methylase inhibitor | 0.134 0.133 DBMET02073 0.276 0.036 DBMET02075 0.141 0.126 DB12529 | DBMET02075 | |
| 0.011 | 0.149 | 0.041 | Carnitine palmitoyltransferase 1 inhibitor | 0.041 0.015 DBMET02075 | DBMET02075 | |
| 0.06 | 0.201 | 0.103 | CC chemokine 5 receptor agonist | 0.095 0.028 DBMET00531 0.103 0.019 DB12529 | DB12529 | |
| 0.032 | 0.174 | 0.144 | Acetylcholine nicotinic antagonist | 0.144 0.022 DBMET02075 | DBMET02075 | |
| 0.01 | 0.153 | 0.041 | Carnitine palmitoyltransferase inhibitor | 0.041 0.015 DBMET02075 | DBMET02075 | |
| 0.081 | 0.226 | 0.125 | Heat shock protein 90 alpha antagonist | 0.125 0.119 DBMET02073 | DBMET02073 | |
| 0.028 | 0.174 | 0.088 | Nicotinic alpha4beta2 receptor antagonist | 0.076 0.054 DBMET00531 0.088 0.042 DB12529 | DB12529 | |
| 0.019 | 0.167 | 0.047 | Prolyl endopeptidase inhibitor | 0.046 0.043 DBMET00531 0.047 0.04 DB12529 | DB12529 | |
| 0.037 | 0.186 | 0.081 | Myeloperoxidase inhibitor | 0.081 0.065 DB12529 | DB12529 | |
| 0.022 | 0.171 | 0.045 | CC chemokine 4 receptor antagonist | 0.045 0.037 DB12529 | DB12529 | |
| 0.118 | 0.27 | 0.198 | Transcription factor NF kappa B inhibitor | 0.198 0.171 DBMET02073 | DBMET02073 | |
| 0.03 | 0.183 | 0.066 | Cathepsin G inhibitor | 0.066 0.059 DB12529 | DB12529 | |
| 0.083 | 0.238 | 0.147 | MAP kinase kinase 2 inhibitor | 0.147 0.124 DB12529 | DB12529 | |
| 0.039 | 0.198 | 0.078 | Inducible nitric-oxide synthase inhibitor | 0.078 0.066 DB12529 | DB12529 | |
| 0.027 | 0.188 | 0.051 | Fatty acid synthase inhibitor | 0.051 0.05 DB12529 | DB12529 | |
| 0.014 | 0.176 | 0.052 | RNA-directed RNA polymerase inhibitor | 0.052 0.012 DBMET02075 | DBMET02075 | |
| 0.008 | 0.17 | 0.037 | Potassium channel small-conductance Ca-activated activator | 0.034 0.019 DBMET00531 0.037 0.017 DB12529 | DB12529 | |
| 0.011 | 0.173 | 0.028 | 5 Hydroxytryptamine 6 agonist | 0.028 0.022 DB12529 | DB12529 | |
| 0.046 | 0.21 | 0.187 | 5 Hydroxytryptamine 3A agonist | 0.187 0.019 DBMET00531 0.107 0.068 DBMET02074 0.186 0.019 DB12529 | DBMET00531 | |
| 0.006 | 0.171 | 0.022 | Imidazoline I1 receptor antagonist | 0.019 0.017 DBMET00531 0.022 0.012 DB12529 | DB12529 | |
| 0.058 | 0.225 | 0.09 | Phosphodiesterase 6D inhibitor | 0.089 0.077 DBMET00531 0.09 0.075 DB12529 | DB12529 | |
| 0.064 | 0.235 | 0.174 | Aryl hydrocarbon receptor agonist | 0.174 0.118 DB12529 | DB12529 | |
| 0.048 | 0.221 | 0.095 | Protein kinase C gamma inhibitor | 0.095 0.086 DB12529 | DB12529 | |
| 0.08 | 0.254 | 0.163 | I kappa B kinase epsilon inhibitor | 0.145 0.125 DBMET00531 0.163 0.106 DB12529 | DB12529 | |
| 0.066 | 0.242 | 0.138 | Pyruvate kinase inhibitor | 0.138 0.127 DB12529 | DB12529 | |
| 0.044 | 0.22 | 0.094 | Nitric-oxide synthase inhibitor | 0.094 0.07 DB12529 | DB12529 | |
| 0.037 | 0.216 | 0.062 | Histone deacetylase SIRT3 inhibitor | 0.06 0.048 DBMET00531 0.062 0.044 DB12529 | DB12529 | |
| 0.033 | 0.214 | 0.079 | Potassium channel (Tandem pore domain) blocker | 0.079 0.037 DBMET00531 0.079 0.036 DB12529 | DB12529 | |
| 0.014 | 0.198 | 0.028 | Glucosylceramidase stimulant | 0.028 0.017 DBMET00531 0.028 0.018 DB12529 | DB12529 | |
| 0.017 | 0.201 | 0.037 | 5 Hydroxytryptamine 2B agonist | 0.037 0.032 DB12529 | DB12529 | |
| 0.014 | 0.198 | 0.036 | Delayed rectifier potassium channel blocker | 0.036 0.028 DBMET00531 0.036 0.029 DB12529 | DB12529 | |
| 0.097 | 0.282 | 0.264 | 5 Hydroxytryptamine 1E antagonist | 0.238 0.088 DBMET00531 0.207 0.122 DBMET02074 0.264 0.06 DB12529 | DB12529 | |
| 0.081 | 0.267 | 0.31 | Spasmolytic | 0.31 0.066 DB12529 | DB12529 | |
| 0.048 | 0.236 | 0.095 | Proteasome inhibitor | 0.095 0.094 DB12529 | DB12529 | |
| 0.006 | 0.194 | 0.041 | HCV NS5B polymerase inhibitor | 0.041 0.014 DBMET02075 | DBMET02075 | |
| 0.021 | 0.212 | 0.046 | HCV NS3/NS4A protease inhibitor | 0.046 0.04 DB12529 | DB12529 | |
| 0.07 | 0.266 | 0.127 | Neuropeptide Y1 antagonist | 0.127 0.107 DB12529 | DB12529 | |
| 0.028 | 0.239 | 0.069 | Corticotropin releasing factor 2 receptor antagonist | 0.067 0.032 DBMET00531 0.069 0.029 DB12529 | DB12529 | |
| 0.07 | 0.284 | 0.188 | Platelet adhesion inhibitor | 0.188 0.078 DBMET02073 | DBMET02073 | |
| 0.017 | 0.231 | 0.067 | Diacylglycerol O-acyltransferase inhibitor | 0.067 0.021 DBMET02075 | DBMET02075 | |
| 0.024 | 0.239 | 0.123 | Protein kinase (CK2) inhibitor | 0.123 0.046 DB12529 | DB12529 | |
| 0.107 | 0.333 | 0.2 | Neuropeptide Y2 antagonist | 0.191 0.137 DBMET00531 0.2 0.119 DB12529 | DB12529 | |
| 0.025 | 0.254 | 0.136 | Protein kinase (CK2) alpha inhibitor | 0.136 0.051 DB12529 | DB12529 | |
| 0.026 | 0.259 | 0.057 | Phosphodiesterase 1A inhibitor | 0.057 0.049 DB12529 | DB12529 | |
| 0.076 | 0.313 | 0.192 | Calpain inhibitor | 0.192 0.121 DB12529 | DB12529 | |
| 0.021 | 0.274 | 0.053 | 5 Hydroxytryptamine 7 agonist | 0.053 0.045 DB12529 | DB12529 | |
| 0.089 | 0.342 | 0.169 | Histone acetyltransferase inhibitor | 0.169 0.114 DB12529 | DB12529 | |
| 0.029 | 0.294 | 0.078 | Caspase 7 inhibitor | 0.076 0.071 DBMET00531 0.078 0.065 DB12529 | DB12529 | |
| 0.038 | 0.307 | 0.134 | Cholinergic antagonist | 0.134 0.062 DBMET02075 | DBMET02075 | |
| 0.081 | 0.35 | 0.232 | Calpain 2 inhibitor | 0.232 0.162 DB12529 | DB12529 | |
| 0.037 | 0.308 | 0.129 | Acetylcholine antagonist | 0.129 0.063 DBMET02075 | DBMET02075 | |
| 0.102 | 0.382 | 0.276 | Sodium/bile acid cotransporter inhibitor | 0.276 0.102 DBMET02075 | DBMET02075 | |
| 0.037 | 0.319 | 0.089 | Bromodomain-containing protein 2 inhibitor | 0.089 0.057 DBMET00531 0.089 0.056 DB12529 | DB12529 | |
| 0.085 | 0.369 | 0.212 | Hypoxia-inducible factor 1 alpha inhibitor | 0.212 0.138 DBMET02075 | DBMET02075 | |
| 0.006 | 0.304 | 0.039 | Prostaglandin D2 agonist | 0.039 0.013 DBMET02075 | DBMET02075 | |
| 0.073 | 0.398 | 0.185 | Transcription factor STAT3 inhibitor | 0.185 0.156 DB12529 | DB12529 | |
| 0.029 | 0.38 | 0.132 | Nav1.6 sodium channel blocker | 0.124 0.089 DBMET00531 0.132 0.078 DB12529 | DB12529 | |
| 0.056 | 0.422 | 0.174 | Lipoxygenase inhibitor | 0.174 0.172 DBMET02075 | DBMET02075 | |
| 0.03 | 0.405 | 0.222 | Diuretic | 0.222 0.037 DB12529 | DB12529 | |
| 0.047 | 0.474 | 0.21 | Tumour necrosis factor antagonist | 0.21 0.048 DBMET02075 | DBMET02075 | |
| 0.041 | 0.468 | 0.195 | Thioredoxin glutathione reductase inhibitor | 0.195 0.177 DBMET02073 | DBMET02073 | |
| 0.016 | 0.468 | 0.045 | Glucose-6-phosphate dehydrogenase inhibitor | 0.045 0.015 DBMET02075 | DBMET02075 | |
| 0.005 | 0.463 | 0.055 | Protein 30S ribosomal subunit inhibitor | 0.055 0.007 DBMET02075 | DBMET02075 | |
| 0.004 | 0.629 | 0.071 | Microtubule stabilization | 0.071 0.006 DBMET02075 | DBMET02075 | |
| 0.012 | 0.739 | 0.15 | Nitric oxide antagonist | 0.15 0.095 DBMET02075 | DBMET02075 | |
| 0.005 | 0.921 | 0.222 | Platelet antagonist | 0.222 0.087 DB12529 | DB12529 | |
| 0.006 | 0.954 | 0.163 | Elastase 1 inhibitor | 0.163 0.005 DBMET02075 | DBMET02075 | |
| 0.005 | 0.975 | 0.779 | Immunosuppressant | 0.693 0.005 DBMET02075 0.779 0.004 DB12529 | DB12529 | |
| 0.004 | 0.987 | 0.149 | Hypolipemic | 0.149 0.137 DBMET02073 | DBMET02073 | |
| 0.004 | 0.992 | 0.938 | Cyclophilin D inhibitor | 0.938 0.004 DBMET02074 | DBMET02074 | |
| 0.004 | 0.995 | 0.188 | Antimitotic | 0.188 0.091 DBMET02075 | DBMET02075 | |
| 0.004 | 0.996 | 0.852 | Antiinflammatory | 0.852 0.009 DB12529 | DB12529 | |
| 0.003 | 0.996 | 0.999 | Analgesic | 0.999 0 DB12529 | DB12529 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |